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Purpose. Cellular entry of biomacromolecules is restricted by the barrier function of cell membranes.
Tethering such molecules to cell penetrating peptides (CPPs) that can translocate cell membranes has
opened new horizons in biomedical research. Here, we investigate the cellular internalization of hCT(9-
32)-br, a human calcitonin derived branched CPP, and SAP, a g-zein related sequence.
Methods. Internalization of fluorescence labelled CPPs was performed with both proliferating and
confluent MDCK cells by means of confocal laser scanning microscopy (CLSM) and fluorescence
activated cell sorting (FACS) using appropriate controls. Internalization was further elaborated in an
inflammatory, IFN-g/TNF-! induced confluent MDCK model mimicking inflammatory epithelial
pathologies. Activities of active form Rho-GTPases (Rho-A and Rac-1) in proliferating and confluent
MDCK cells were monitored by pull-down assay and Western blot analysis.
Results. We observed marked endocytic uptake of the peptides into proliferating MDCK by a process
suggesting both lipid rafts and clathrin-coated pits. In confluent MDCK, however, we noted a massive
but compound-unspecific slow-down of endocytosis. This corresponded with a down-regulation of
endocytosis by Rho-GTPases, previously identified to be intimately involved in endocytic traffic. In fact,
we found endocytic internalization to relate with active Rho-A; vice versa, MDCK cell density, degree of
cellular differentiation and endocytic slow-down were found to relate with active Rac-1. To our
knowledge, this is the first study to cast light on the previously observed differentiation restricted
internalization of CPPs into epithelial cell models. In the inflammatory IFN-g/TNF-! induced confluent
MDCK model mimicking inflammatory epithelial pathologies, CPP internalization was enhanced in a
cytokine concentration-dependent way resulting in maximum enhancement rates of up to 90%. We
suggest a cytokine induced redistribution of lipid rafts in confluent MDCK to cause this enhancement.
Conclusion. Our findings emphasize the significance of differentiated cell models in the study of CPP
internalization and point towards inflammatory epithelial pathologies as potential niche for the
application of CPPs for cellular delivery.
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INTRODUCTION
The plasma membrane of mammalian cells widely restricts
the passage of large, charged and hydrophilic compounds into
cells, preventing most peptide, protein and nucleic acid
biopharmaceuticals to reach intracellular targets, and frequent-
ly results in low or zero biological efficacy. Cell penetrating
peptides (CPPs) constitute a collection of various families of
short peptide sequences that have been shown to translocate
across the plasma membrane via different mechanisms. The
prospects of chemical ligations or physical assemblies between
CPPs and therapeutic cargoes has, therefore, attracted
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considerable interest, and created widespread hopes to exploit
the CPP approach for drug delivery purposes, gene therapy
and vaccine development (1,2). Various oligocationic cell
penetrating peptides, e.g., HIV-1 derived Tat peptides,
penetratin (pAntp), oligoarginine peptides or the weakly
cationic, human calcitonin derived CPPs and others, have
been described in the literature in broad detail (3–7). They
were commonly considered for the therapeutic delivery of
peptides, proteins, oligonucleotides, plasmids, peptide
nucleic acids (PNAs) and even nanoparticles (8–13).
In this study, we investigate the cellular entry of two
recently developed, N-terminally carboxyfluorescein (CF)
labelled, oligocationic CPPs. One is a branched derivative
of the linear human calcitonin derived CF-hCT(9-32) (7),
denoted as CF-hCT(9-32)-br, that carries an oligocationic, SV40
derived nuclear localisation sequence, the GPDEVKRKKKP
motif, in the form of a side-branch to the main peptide chain
(see Table I) (14). The other one is the proline-rich sweet
arrow peptide CF-SAP (see Table I), a linear trimer of
repetitive VRLPPP domains, and conceived as an amphipathic
version of a polyproline sequence related to g-zein, a storage
protein of maize (15–17). The internalization of both CPPs
into HeLa cells was recently found to follow the pathway of
lipid raft-mediated endocytosis prior to endosomal escape (18).
Diverse mammalian cell lines have been used to study
the internalization of CPPs across the plasma membrane. In
the majority of cases, Bleaky^ cell models, such as HeLa, KB
3-1, Bowes Human Melanoma or MC57 fibrosarcoma cells,
have been used for CPP internalization (19–23). When
cultured on solid surfaces such cell lines lack the ability to
form tight junctions and form cell layers of high permeability
(24). Cellular models with junctional complexes bear more
relevance for therapeutic considerations, namely for the
delivery of CPP-cargo constructs into epithelia. Therefore,
part of our recent research has been concentrated on
internalization studies in epithelial like models with fully
developed tight junctions (7). One of the best characterized
epithelial models derives from the Madin-Darby canine
kidney (MDCK) cell line. When grown to confluence,
MDCK cells feature key elements of well-differentiated,
polarized epithelia, such as apical–basolateral polarization
and tight junctions. Therefore, MDCK monolayers represent
an established in vitro model for various absorptive and
respiratory epithelia (25,26). The architecture of the plasma
membrane of polarized epithelial cells is well characterized
(27,28). Epithelial cells are connected by a junctional
complex encircling the apex of each cell. Tight junctions are
the most apical structure of the junctional complex which
also includes adherens junctions, desmosomes and gap
junctions. Tight junctions constitute a barrier to the para-
cellular diffusion of solutes from the lumen to the tissue
parenchyma (gate function) and restrict the lateral exchange
of lipids and proteins between the apical and basolateral
plasma membrane domains (fence function) (29–33).
Cell line dependence of CPP internalization has been
suggested by different research groups (7,23,24). Previously,
Hallbrink et al. (34) hypothesized about a cell density
dependent internalization of CPPs. In the present study, we
demonstrate a differentiation state dependence of the
process and efficiency of internalization. With proliferating
MDCK we observed marked endocytic internalization of two
CPPs by a process that is suggested to involve both lipid rafts
and clathrin-coated pits. In contrast, for well-differentiated,
confluent MDCK monolayers we noted a massive slow-down
of compound unspecific endocytosis and no detectable
contribution of lipid raft-mediated endocytosis.
The Rho family of small GTPases, comprising Rho, Rac
and Cdc42, are ubiquitously expressed across eukaryotes
where they act as molecular switches, cycling between an
active GTP-bound state and an inactive GDP-bound state
(35,36). In the active state, they interact with various
downstream effectors and regulate a variety of cellular events
such as actin polymerization, cell morphology and polarity,
cell growth control, transcription and membrane trafficking
events such as endocytosis (37–42). They are ideally placed to
mediate the signalling interface between endocytic traffic and
the actin cytoskeleton (43,44). Considering the close apposi-
tion between the perijunctional F-actin ring and the epithelial
tight junction complex, it is conceivable that Rho-GTPases,
through cytoskeletal modification, could affect epithelial
barrier function (45). In the present study, we investigated
the contents of GTP-bound, active form Rho-A and Rac-1,
respectively, in 1 day old MDCK cells with low or high
seeding density as well as in 10 day old, well-differentiated
MDCK cells with high cell culture density, in order to
elucidate a potential relationship between cellular differenti-
ation and endocytic activity, respectively, and Rho-GTPase
activation. In fact, we found correspondence between endo-
cytic internalization and active form Rho-A; vice versa, cell
density, cellular differentiation and endocytic slow-down
were observed to relate with active form Rac-1. To our
knowledge, this is the first study that casts light on the role of
Rho-GTPases for the differentiation restricted endocytosis of
CPPs into an epithelial cell model.
The correspondence between endocytic slow-down and
cellular differentiation was further elaborated using an
inflammatory, IFN-g/TNF-! induced model mimicking in-
flammatory epithelial diseases. Inflammatory epithelial pa-
thologies such as inflammatory bowel diseases, e.g. Crohn_s
disease and ulcerative colitis (46–50), or inflammatory airway
diseases associated with cystic fibrosis (51) or asthma
bronchiale (52), typically show increased cytokine production,
Table I. Name, Sequence, and Origin of the Cell-Penetrating Peptides(CPPs) Useda
Name Sequence Origin
hCT(9-32)-br LGTYTQDFNKFHTFPQTAIGVGAP-NH2
|
AFGVGPDEVKRKKKP-NH2
human calcitonin,
simian virus 40
SAP VRLPPP-VRLPPP-VRLPPP modified maize
Tat(FITC) GRKKRRQRRRGYK(FITC)C-NH2 HIV-1
a hCT(9-32)-br and SAP were CF-labeled at the N-terminus
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and significant barrier dysfunction. In particular, we tested
whether the internalization efficiency of the investigated CPPs
is enhanced when studied in a cytokine pretreated, inflamma-
tory MDCK model, possibly triggered by a cytokine induced
redistribution of lipid rafts. Altogether, our findings emphasize
the importance of relevant cell models to study CPP internal-
ization and point towards inflamed epithelia as potential niche
for CPPs as drug delivery vehicles.
MATERIALS
MDCK cells (low resistance, type II) were kind gifts from
the Biopharmacy group (ETH Zurich, Switzerland). Cell
culture media, trypsin-EDTA, penicillin, streptomycin and
Hank_s Balanced Salt Solution (HBSS) were from Gibco
(Paisley, UK). Phosphate buffer solution (PBS, pH 7.4) without
calcium and magnesium were from Life Technologies (Basel,
Switzerland). Foetal calf serum (FCS) was purchased from
Winiger AG (Wohlen, Switzerland). Hoechst 33342, cholera
toxin subunit B (recombinant), Alexa Fluor 594 conjugate and
tetramethylrhodamine-labelled transferrin were from Molecu-
lar Probes (Leiden, The Netherlands). 5(6)-carboxyfluorescein
(CF), Trypan blue, sodium azide (NaN3), Triton X-100, 2-
deoxy-glucose, Tris(hydroxymethyl)-aminomethane hydro-
chloride, Tween 20 and bovine serum albumin (BSA) were
obtained from Fluka (Buchs, Switzerland), and methyl-b-
cyclodextrin (M-b-CD) from Wacker-Chemie (Munich, Ger-
many). EZ-Detect Rho and Rac1 activation kits as well as
Halt Protease Inhibitor Cocktail (EDTA free) were from
Perbio Science (Lausanne, Switzerland). The polyclonal pri-
mary antibody rabbit Anti-ZO-1 was from Zymed Laborato-
ries (South San Francisco, CA), the secondary antibodies goat
anti-rabbit Texas red and goat anti-mouse conjugated with
horseradish peroxidase were from Jackson ImmunoResearch
Laboratories (West Grove, PA). E. coli derived recombinant
canine interferon-gamma (IFN-g) and tumor necrosis factor-
alpha (TNF-!) were obtained from R&D Systems (Minneap-
olis, MN). Filter inserts (polyethylene terephthalate (PET),
0.4 mm pore size), companion 12 well plates, 24 well plates
and 5 ml polypropylene round-bottom tubes (FACS tubes)
were purchased from Falcon (Becton Dickinson Labware,
Franklin Lakes, NJ). 96 well plates and glass chamber slides
were obtained from Nunc (Roskilde, Denmark). MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide), Fluo-
rescein isothiocyanate-dextran (FITC-dextran, MW 4400),
mouse anti-actin, sodium dodecyl sulphate (SDS) and Brad-
ford reagent were from Sigma (St. Louis, MO). Cell culturing
flasks (25 and 75 cm2) were from TPP (Trasadingen,
Switzerland). Centricon centrifugal filter devices were
obtained from Millipore (Billerica, MA). ECL Plus Western
Blotting Detection Reagent was from Amersham Biosciences
(Uppsala, Sweden). [3H]-mannitol (19.7 Ci/mmol) was from
Perkin Elmer (Boston, MA). Coverslips and microscope
slides were purchased from Knittel (Braunschweig, Germany).
METHODS
Peptide synthesis. Investigated CPPs are listed in
Table I. The branched human calcitonin (hCT) derived
CPP (hCT(9-32)-br was synthesized by the peptide synthesis
unit of the University of Barcelona (Barcelona, Spain). This
peptide is derived from the human calcitonin fragment
hCT(9-32) and is equipped with the nuclear localization
sequence (NLS) of simian virus 40 large T antigen in the side
chain of K18 (14). N-terminal fluorescently labelled sweet
arrow peptide (CF-SAP) was synthesised by solid-phase
peptide synthesis on a 2-chlorotrityl resin following the 9-
fluorenyl methoxy carbonyl/tert-butyl (Fmoc/tBu) strategy
prior to fluorescent labeling with 5(6)-carboxyfluorescein
(CF) (16). Finally, a FITC labelled Tat peptide with the
sequence GRKKRRQRRRGYK(FITC)C–NH2 (MW 2237)
was synthesized and purified as described previously (53).
Cell culture. MDCK cells were cultured under standard
conditions in minimum essential medium with Earl_s salts
(MEM) containing 10% heat-inactivated FCS and 1%
penicillin/streptomycin. Cells were used between passage
numbers 227 and 237. For internalization experiments, if
not otherwise indicated, cells were seeded at a constant
density of 2 104 cells/cm2 on Transwell filters in 12 or 24-
well plates or on chamber glasses and incubation was at 37-C.
Cells were used in both proliferating and confluent states,
starting from 12 h post seeding until 10 days post seeding. For
detection of filter grown cells, filters were cut out, put upside
down on coverslips and mounted in Dako mounting medium.
Cell numbers were determined with a haemocytometer
(Assistent, Sondheim/Rho¨n, Germany). Throughout the
study, all experiments were performed in triplicate (n = 3),
unless otherwise indicated.
Confocal laser scanning microscopy (CLSM) of CPP
internalization. MDCK cells were incubated with serum free
MDCK medium containing either CF-SAP (50 mM), CF-
hCT(9-32)-br (30 mM) or unconjugated fluorophore (50 mM
or 30 mM, respectively) for 1 h under horizontal mechanical
shaking at 150 minj1. After 30 min, Hoechst 33342 was
added to a final concentration of 1 mg/ml for nuclear staining.
To inhibit endocytosis, 1 or 10 day old cells were pre-
treated for 1 h with NaN3/2-deoxyglucose (0.1%/50 mM in
HBSS) prior to incubation with CPPs. To study the temper-
ature dependence on internalization, studies were carried out
at 4 and 37-C. For colocalization studies, cells were co-
incubated apically for 30 min in solutions of CF-SAP (50 mM)
or CF-hCT(9-32)-br (30 mM) with either cholera toxin (10 mg/ml)
or transferrin (50 mg/ml) in serum free MDCK medium.
Subsequently, all samples were washed with phosphate
buffered saline (PBS), fixed in 1% (w/v) aqueous parafor-
maldehyde (PFA) solution for 30 min and washed again. To
exclude artifacts owing to cell fixation, preliminary experi-
ments were also performed in unfixed, living cells. Both
protocols led to identical vesicular distributions of the two
CPPs as well as to identical colocalization patterns with
transferrin and cholera toxin. Therefore, we followed a mild
fixation protocol with 1% PFA for better handling and to
definitively terminate the experiments. Cellular uptake was
visualized using a TCS-SP2 laser scanning confocal micro-
scope (Leica Microsystems, Mannheim, Germany) with a
63, 1.4 NA, plan-apochromatic lens using HeNe 594 nm,
HeNe 543 nm, Ar 488 and diode 405 nm lasers. To avoid
cross talk, emission signals were collected independently. 3-D
multichannel image processing was performed using the
IMARIS software (Bitplane AG, Zurich, Switzerland) on a
Silicon graphics workstation. Background fluorescence was
determined by analysing unlabelled cells. The images were
630 Foerg et al.
deconvolved using Huygens software (Scientific Volume
Imaging B.V., Hilversum, Netherlands). Colocalization
images were obtained by the colocalization program of
IMARIS software (Bitplane AG, Zurich, Switzerland).
Internalization and endocytosis inhibition study by
FACS. Individual MDCK cultures were used for experi-
ments after 12 h, 1 day and then every 24 h until 10 days
post seeding. Cells were incubated from either the apical or
the basolateral side with CF-SAP (50 mM), hCT(9-32)-br
(30 mM) or unconjugated fluorophore (50 mM or 30 mM,
respectively) in serum free MDCK medium for 3 h.
Additional experiments were performed, incubating
MDCK cells with 30 mM FITC-dextran, 5 mM Tat peptide,
and 30 mM hCT(9-32), respectively, from the apical side or
30 mM transferrin from the basolateral side for 3 h. After
incubation, cells were washed, trypsinized for 10 min, re-
suspended in medium and immediately put on ice. To quench
potentially remaining external fluorescence, Trypan blue was
added to the samples prior analysis by FACS on a FacScan
(Becton Dickinson, Franklin Lakes, NJ) or a FACSCalibur
(Becton Dickinson, Franklin Lakes, NJ) within 2 h after
trypsinization. A total of 10,000 cells per sample were analyzed.
The mean fluorescence intensity of peptide-labelled cell
populations was normalized to unlabelled control cells and
compared to control cells labelled with 5(6)-carboxyfluorescein.
To study the effects of seeding and cell culture density in
MDCK layers, FACS studies were performed comparing half
or 1 day old cells with a low seeding density of 2 104 cells/
cm2, half or 1 day old cells having a high seeding density of
5 105 cells/cm2, and, finally, 10 day old cells with a low initial
seeding density of 2 104 cells/cm2 but a high final cell
culture density of 5 105 cells/cm2, after 10 days. Cells were
incubated from the apical side with CF-SAP (50 mM), hCT
(9-32)-br (30 mM) or unconjugated fluorophore (50 mM or
30 mM, respectively) in serum free MDCK medium for 3 h.
Quantification was performed as described above.
For inhibition of endocytosis, 1 or 10 days old cells were
pre-treated for 1 h with NaN3/2-deoxyglucose (0.1%/50 mM
in HBSS) or M-b-CD (10 mM in serum free MDCK medium)
prior to incubation with CPPs. Statistical significance of
internalization was evaluated by pairwise t tests (n = 3).
Furthermore, temperature-dependent internalization was
studied at 4 and 37-C.
ZO-1 staining monitored by CLSM. MDCK cells seeded
on filter inserts in 12-well plates were incubated with 1 mg/ml
Hoechst 33342 to stain the nuclei. After several washing
steps, cells were fixed for 30 min in 1% (v/v) PFA and
permeabilized with 0.1% Triton X-100 in PBS for 1 min.
Non-specific binding sites were blocked by incubating for
30 min with 1% BSA in PBS. Cells were then incubated for
1 h with polyclonal antibody rabbit anti-ZO-1 (0.5 mg/ml) in
1% BSA in PBS. After another washing step, cells were
incubated with goat anti-rabbit Texas red (4 mg/ml) in 1% BSA
in PBS for 1 h and washed again. Cells were scanned as described
for colocalization studies. As control experiments, cells incu-
bated with secondary antibodies without primary antibody
staining confirmed the high specificity of the antibodies.
To investigate the ZO-1 distribution in the inflammato-
ry epithelial model, 10 day old MDCK cells were treated for
24 h with a combination of 100 ng/ml IFN-g and 1 ng/ml
TNF-! in the apical and basolateral compartments, prior to
ZO-1 antibody staining as described above and CLSM
analysis. For graphical representation of ZO-1 distribution
we used the maximum intensity projection as provided by
IMARIS software (Bitplane AG, Zurich, Switzerland).
TEER measurement. MDCK cells were cultured as
described above. Transepithelial electrical resistance
(TEER) was measured in an Endohm tissue resistance
measurement chamber (World Precision Instruments, Inc.,
Sarasota, USA.) and monitored with a Millicell-ERS meter
(Millipore/Continental Water Systems, Bedford, USA.) as
previously described (54). To obtain values independent of
the membrane area, TEER measurements were multiplied
by the effective membrane area and reported as W cm2. All
measurements were reported as net TEER (total minus the
mean TEER of two cell-free inserts). We also performed
TEER measurement in an inflammatory epithelial model.
10 day old MDCK cells were treated for 24 h with
combinations of 10–1,000 ng/ml IFN-g and 0.1–1,000 ng/ml
TNF-! in the apical and basolateral compartments, prior to
TEER measurement as described above. After a cytokine
treatment for 2 days, IFN-g and TNF-! were removed, cells
washed with PBS and TEER recovery was measured.
Measurement of active form Rho-A and Rac-1 (pull-
down assay and Western blot analysis). Active-form Rho-A
or Rac-1, respectively, were measured in 0.5, 1 or 10 day
old MDCK cell cultures with cell seeding densities as
described for density experiments. MDCK cells grown in
75 cm2 flasks were lysed in lysis buffer plus protease
inhibitor (25 mM TrisHCl, pH 7.5, 1% NP-40, 150 mM
NaCl, 5 mM MgCl2, 1 mM DTT, 5% glycerol, 1 mg/ml each
of aprotinin and leupeptin, and 1 mM PMSF) and clarified
by centrifugation at 16,000g at 4-C for 15 min. Cell lysates
were incubated with GST-Rhotekin-RBD or GST-human
Pak1-PBD to pull down active Rho-A or Rac-1 in the
presence of Swell Gel immobilized glutathione at 4-C for 1 h.
After incubation, the mixture was centrifuged at 8,000g to
remove unbound proteins. The resins were washed several
times with lysis buffer and the sample was eluted by adding
50 ml of SDS sample buffer (5% b-mercaptoethanol, 125 mM
TrisHCl, pH 6.8, 2% glycerol, 4% SDS (w/v) and 0.05%
bromophenol blue) and boiling at 95-C for 5 min. 20 ml of the
sample volume were analyzed by SDS page and transferred
to a nitrocellulose membrane. Unfractionated cell lysates
were included for protein quantification and to verify that the
Western blot analysis functioned properly. Active Rho-A
and Rac-1 were detected by using a specific mouse
monoclonal anti-Rho (0.7 mg/mL) or anti-Rac1 (0.5 mg/mL)
antibody. Goat anti-mouse antibody conjugated with
horseradish peroxidase (0.04 mg/mL) was used as the
secondary antibody. To ensure equal protein content of the
samples, actin was quantified by a specific mouse monoclonal
anti-actin antibody (0.04 mg/mL). Detection was performed
with Chemiluminiscent Substrate followed by exposure to
X-ray film (average exposure time was 10 s to 5 min). All
assays were run in triplicate using independent samples.
Bradford test. To normalize for protein content for all
samples of active form Rho-A or Rac-1 analyses, we
determined protein contents by performing Bradford tests
as described by the manufacturer. Absorption was measured
at 570 nm using a ThermoMax microplate reader (Molecular
Device, Sunnyvale, CA).
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CPP internalization in an inflammatory MDCK model as
studied by FACS. Filter grown 10 day old MDCK cells were
treated with MDCK medium containing 10–1,000 ng/ml
IFN-g and 0.1–1,000 ng/ml TNF-! for 24 h. Cytokines were
present in both the apical and the basolateral media. After
washing, cells were incubated from the apical side with CF-
SAP (50 mM), hCT(9-32)-br (30 mM), Tat peptide (5 mM) or
unconjugated fluorophore (50 mM or 30 mM, respectively) in
serum free MDCK medium for 3 h. FACS analysis was
performed as described previously. Pairwise t tests were
performed to reveal the significance of an increase in
internalization between untreated and cytokine treated cells
(1,000 ng/ml IFN-g/10 ng/ml TNF-!) (n = 3).
Influence of cholesterol depletion in the inflammatory
model was studied by pre-treating cells for 1 h with M-b-CD
(10 mM in serum free MDCK medium) prior to incubation
with CPPs. Pairwise t tests were performed to reveal the
significance of a decrease in internalization between untreat-
ed and M-b-CD treated cells (n = 5).
Cytotoxicity assay. An MTT assay was performed to
measure cell viability in the described inflammatory model.
10 day old MDCK cells seeded in 96-well plates were treated
with cytokine solutions of 10–1,000 ng/ml IFN-g and 0.1–
1,000 ng/ml TNF-!, for 24 h, with 70% EtOH for 7 min or
left untreated as control cells. All wells were washed three
times with medium and loaded with 100 ml medium. 10 ml MTT
reagent (5 mg MTT powder in 1 ml PBS) were added to all
wells. After 2 h, the medium was removed and replaced with
100 ml detergent reagent (81% isopropanol, 15% SDS (20%)
and 4% 1 M HCl. After additional 4 h, absorbance was
measured at 570 nm in a ThermoMax microplate reader
(Molecular Device, Sunnyvale, CA).
Transepithelial permeability. 10 day old MDCK cells
seeded on filters in 12-well plates were either treated with
combinations of 10–1,000 ng/ml IFN-g and 0.1–1,000 ng/ml
TNF-! for 24 h or used as untreated control cells. Prior to
permeability measurements, all monolayers were checked for
TEER as described above. Confluent MDCK monolayers
were equilibrated for 30 min in HBSS, pH 7.4. Monolayers
were loaded apically with 0.5 ml HBSS solutions containing
30 mM CF or [3H]-mannitol (4 mCi/ml), respectively and 1.8 ml
of HBSS was added to the basolateral side. Blank wells were
used as controls. Samples of 100 ml were withdrawn from the
basolateral receiver compartment and immediately replaced
with the same volume of HBSS at t = 0, 1, 2 and 4 h. Effective
permeability coefficients of 5(6)-carboxyfluorescein (CF)
were determined by direct fluorescence spectrometry (lex
X492 nm, lem 517 nm; Varian CARY Eclipse, Zug,
Switzerland). CF concentrations transported into the ba-
solateral compartment were extrapolated from a standard
curve and expressed as mM cmj2 hj1 for compound
transported. For [3H]-mannitol permeability studies, the
samples were mixed with 2 ml scintillation cocktail (Ultima
Gold, PerkinElmer Life Sciences, Beltsville, MD) and
radioactivity was counted using a liquid scintillation
spectrometer from Beckman (Model LS 6500, Fullerton, CA).
RESULTS
CPP internalization in MDCK cells. Cellular internali-
zation of either of the two cationic CPPs (CF-SAP or CF-
hCT(9-32)-br) occurred in proliferating MDCK cells 1 day post
seeding as shown by CLSM (Fig. 1a or b, left insets, respective-
ly). At this time point the internalized fluorescence featured a
punctate pattern indicating localization in discrete vesicular
compartments in the cytoplasm typical for endocytosis (55). In
contrast, confluent monolayers, 10 days post seeding with well-
established cell-to-cell contacts, enabled significantly less inter-
nalization (Fig. 1a or b, right insets). The occurence of punctate
fluorescence in the cytoplasm was markedly reduced, and the
CPPs accumulated mainly in the junctional complex. Unla-
belled cells and cells incubated with the fluorescence marker
carboxyfluorescein alone were analysed as controls. No cellular
fluorescence was observed in both cases (data not shown).
FACS analysis of CPP internalization. To confirm the
contrasts in internalization in proliferating versus confluent
MDCK cells, we quantified the internalization of CF-SAP
Fig. 1. Internalization of CF-SAP and CF-hCT(9-32)-br in MDCK
cells varying in their state of differentiation (FACS and CLSM).
MDCK cells from 12 h up to 10 days post seeding were incubated for
3 h with 50 mM CF-SAP (a) or 30 mM CF-hCT(9-32)-br (b) (FACS).
Fluorescence intensities were normalized to control cells of the same
age. Inserted CLSM pictures show incubation of 1 or 10 day old
MDCK cells with CF-SAP (1A, left or right picture, respectively) or
CF-hCT(9-32)-br (1B, left picture or right picture, respectively) for 1 h.
The scale bar is 10 mm. CPPs in green, nuclei in blue. Colors indicated
in electronic version only.
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and CF-hCT(9-32)-br, respectively, by FACS analysis. As
shown in Fig. 1a and b, internalization in proliferating
MDCK was marked for both CPPs, and similar whether
treated from the apical or the basolateral side. With
increasing culture time, however, the degree of internaliza-
tion from both the apical and the basolateral sides decreased
strikingly. At confluence, i.e. after a growth period of 4 days,
apical internalization reached a baseline level of around one
tenth of the initial value and stayed constant for the rest of
the growth period. Internalization rates from the basolateral
side followed a similar trend but were around twice as high
than those from the apical side, probably resulting from the
higher surface area of the basolateral membrane. Fluores-
cence intensities were normalized to untreated control
cultures of the same age.
Endocytic internalization into proliferating and confluent
MDCK layers. To further identify the internalization mech-
anisms of CF-SAP and CF-hCT(9-32)-br in proliferating and
confluent MDCK cells, we analysed by FACS the internal-
ization under conditions which inhibited endocytosis. Non-
treated cells and cells incubated with carboxyfluorescein
alone (data not shown) were used as negative controls. At
4-C, internalization of CF-SAP and CF-hCT(9-32)-br, re-
spectively, was strongly reduced in both proliferating and
confluent MDCK cells (Fig. 2a and b). Previously, inhibition
of endocytosis at 4-C was not only attributed to a blockade of
active processes but also to rigidification of lipid membranes
at this temperature (56). Therefore, we also tested CPP
internalization at 37-C after pre-incubation with NaN3/2-
deoxyglucose, which was expected to impair energy-depen-
dent internalization by ATP depletion. As shown in Fig. 2a
and b, internalization of both peptides in proliferating as well
as confluent MDCK cells was blocked through pre-treatment
with NaN3/2-deoxyglucose, supporting energy-dependent
internalization mechanisms such as endocytosis as the
underlying internalization mechanism in proliferating as well
as confluent MDCK cells.
Endocytosis in proliferating MDCK cells involves both
lipid rafts and clathrin-coated pits. Lipid rafts are defined by
their cholesterol enrichment. M-b-CD extracts cholesterol from
cell membranes and, therefore, disrupts lipid rafts whereas it
does not affect clathrin-dependent endocytosis (57–60). Hence,
to investigate involvement of lipid raft dependent internaliza-
tion of extracellular CF-SAP and CF-hCT(9-32)-br, we pre-
treated proliferating MDCK cells with M-b-CD prior to
incubation with the CPPs. As shown in Fig. 2a, reduction of
intracellular fluorescence was highly significant in proliferating
MDCK cells, suggesting lipid raft involvement in the endocytic
internalization process. Fluorescence intensities were normal-
ized to untreated control cells.
To confirm this observation, we performed colocaliza-
tion studies of CF-SAP and CF-hCT(9-32)-br with transferrin
and cholera toxin by CLSM. Transferrin is a well-known
marker for endocytic internalization via clathrin-coated pits
(61,62), whereas cholera toxin exploits clathrin-independent,
lipid raft-mediated endocytosis (58–60). To assess whether
the two CPPs were internalized via one of these endocytic
pathways, CF-SAP and CF-hCT(9-32)-br were each mixed
with TRITC-labelled transferrin or Alexa Fluor 594-labelled
cholera toxin, respectively, and the binary mixture incubated
with proliferating MDCK cells (Fig. 2c). Related colocaliza-
tion micrographs demonstrate colocalized vesicles of CPPs
and transferrin or cholera toxin, respectively (Fig. 2c a0, b0, c0,
d0). In detail, Fig. 2c a and a0 shows a corresponding set of
experiments with CF-SAP and cholera toxin, Fig. 2c b and b0
with CF-SAP and transferrin, Fig. 2c c and c0 with CF-hCT(9-
32)-br and cholera toxin, and finally Fig. 2c d and d0 with CF-
hCT(9-32)-br and transferrin. CF-SAP and CF-hCT(9-32)-br
showed partial colocalization with both cholera toxin and
transferrin, suggesting an involvement of lipid rafts as well as
clathrin-dependent endocytosis in the internalization of CF-
SAP and CF-hCT(9-32)-br into proliferating MDCK cells. In
fact, we calculated colocalization rates of the two peptides
with either one of the two endocytosis markers of about 35–
54% (data not shown). Taken together, our results indicate in
a consistent fashion that CF-SAP and CF-hCT(9-32)-br are
internalized by proliferating MDCK cells via endocytosis.
Both lipid rafts and clathrin-coated pits are suggested to be
involved. For the rest of this work we focus exclusively on the
lipid raft mediated pathway.
Endocytic pathway in confluent MDCK cells. To further
investigate the involvement of lipid rafts in the endocytosis of
CF-SAP and CF-hCT(9-32)-br by confluent MDCK, we pre-
treated cell layers with M-b-CD prior to incubation with the
peptides. Fluorescence intensities were normalized to un-
treated control cells. As shown in Fig. 2b, reduction in
intracellular fluorescence was only marginal in the case of
CF-hCT(9-32)-br and absent for CF-SAP (Fig. 2b). As there
was only low internalization of CF-SAP and CF-hCT(9-32)-br
into confluent MDCK cells, colocalization experiments with
endocytosis markers did not yield unequivocal results,
neither in favour nor against involvement of lipid rafts (data
not shown).
Compound unspecific endocytic slow-down. We next
addressed the question whether the observed endocytic
slow-down in CPP internalization was a distinct phenomenon
for CF-SAP and CF-hCT(9-32)-br, or an unspecific feature of
endocytosis in confluent MDCK cells. FITC-dextran and
TRITC-labelled transferrin are well known markers of
endocytosis, whereas CF-hCT(9-32) and FITC-labelled Tat
have been previously reported to be taken up by endocytosis
(7, 62–64). Filter grown MDCK cell cultures ranging from
12 h to 10 days post seeding were incubated with solutions
of FITC-dextran, TRITC-labelled transferrin, CF-hCT(9-32)
and FITC-labelled Tat, respectively. Fluorescence intensities
were normalized to untreated control cells of the same age.
Fig. 3 shows all compounds to be readily taken up in
proliferating MDCK cells whereas the degree of internaliza-
tion decreased markedly with increasing culture time. These
findings suggest that the observed slow-down in the endocy-
tosis of the two investigated CPPs in confluent MDCK cells is
compound unspecific.
Relation of endocytic slow-down with increasing cell
density and formation of tight junctions. Effects of seeding
and cell culture density. To evaluate whether seeding and cell
culture densities had an impact on CPP internalization
efficiency in MDCK cells, we compared internalization rates
of CF-SAP and CF-hCT(9-32)-br, respectively, in half or one
day old MDCK cells of low or high seeding density, as well as
in 10 day old, well-differentiated cell cultures with low
seeding density but high final cell culture density. As shown
in Table II, internalization into cell layers with high initial
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seeding density was much lower than in those of low seeding
density of the same age (õ84% less internalization) indicat-
ing a marked impact of cell seeding density on internalization
efficiency. Still, half or one day old cells with high seeding
density feature slightly higher internalization rates than 10 day
old MDCK cells with a low seeding density but a high final
cell culture density (õ92% less internalization). Fluorescence
intensity of 0.5 day old, low density cells was set to 100%.
TEER measurements. To demonstrate a functional coin-
cidence between the endocytic slow-down of CPP internaliza-
tion and the development of the tight junctional network in
the MDCK cultures we monitored their TEER values during
Fig. 2. Internalization and endocytosis inhibition of CF-SAP or CF-hCT(9-32)-br in MDCK cells (FACS). Proliferating MDCK cells (a) and
confluent MDCK cell (b) were incubated for 3 h at either 37 or 4-C with 50 mM CF-SAP (black bars) or 30 mM CF-hCT(9-32)-br (grey bars).
Endocytosis inhibition was performed by pre-treating cells with 10 mM M-b-CD or 0.1% NaN3/50 mM 2-deoxyglucose (NaN3/DOG) prior to
incubation with CF-SAP or CF-hCT(9-32)-br. Fluorescence intensities are normalized to control cells. Significant and highly significant results
for the reduction of internalization through M-b-CD are indicated as or (t test, n = 3). Colocalization study of CF-SAP and CF-hCT
(9-32)-br with cholera toxin or transferrin, respectively in proliferating MDCK cells. (c) Colocalized vesicles in yellow, peptides (CF-SAP or
CF-hCT(9-32)-br) in green and endocytosis markers (cholera toxin and transferrin) in red. Cells were incubated with 50 mM CF-SAP or 30 mM
CF-hCT(9-32)-br and simultaneously stained with 10 mg/ml cholera toxin or 50 mM transferrin, repectively, for 30 min. Colocalization of both CF-
SAP and CF-hCT(9-32)-br with cholera toxin suggests lipid raft-mediated endocytosis (a,c). Colocalization with transferrin suggests clathrin-
mediated endocytosis (b,d) for both peptides. a CF-SAP and cholera toxin. b CF-SAP and transferrin. c CF-hCT(9-32)-br and cholera toxin. a0,
b0, c0 and d0 (CF-hCT(9-32)-br and transferrin) represent related overlay micrographs showing colocalized vesicles in white. The scale bar is 7 mm.
Colors indicated in electronic version only.
634 Foerg et al.
the growing period of 10 days. As shown in Fig. 4a, TEERs
increased initially and then dropped to a stable value of
around 130 W cm2 after 4 or 5 days.
Tight junctional protein ZO-1 staining. For the same
purpose as with the TEER measurements, we performed
ZO-1 staining in MDCK cell cultures from day 1 until day 10
post seeding. As shown in Fig. 4b, soon after seeding cells
begin to form small cell clusters and establish first cell-to-cell
contacts. Formation of tight junctions immediately started
where cells came into contact, particularly at the corners
between the cells. Day after day, with increasing cell cluster
size, more cell-to-cell contacts were established and after day
4 post seeding a coherent tight junctional network was
formed. At that time point, CPP internalization had yet
reached a lower level and stayed constant for the rest of the
growth period (see Fig. 1a and b). Until day 10 post seeding,
cell culture density continued to increase, resulting in a fully
organized and polarized tightly packed monolayer. Taken
together, the observed endocytic slow-down relates directly
with cell density and the formation of a coherent tight
junctional network.
Monitoring active form Rho-A and Rac-1. Rho-family
GTPases have been previously demonstrated to be intimately
involved in the regulation of endocytic traffic and cellular
differentiation (36,65). To elucidate a potential relationship
between cellular differentiation and endocytic activity, re-
spectively, and Rho-GTPase activation in MDCK cells, we
investigated the expression levels of GTP-bound, active form
Rho-A and Rac-1, respectively, in one day old MDCK cells
with low or high seeding density as well as in 10 day old, well-
differentiated MDCK cells with high cell culture density. As
shown in Fig. 5a and c, the contents of total Rho-A and Rac-1,
respectively, in all three samples were alike, confirming the
equal protein content of all samples measured by a Bradford
test. One day old, low density cells showed the highest contents
of active form Rho-A, whereas active Rho-A was strongly
reduced in 1 day old, but high density cells, and almost
abolished in 10 day old MDCK cells (Fig. 5a). For Rac-1,
inverse activities were observed: almost no active Rac-1 was
found in 1 day old, low density cells, slightly higher contents in 1
day old, high density cells, and high contents in 10 day old
MDCK cells (Fig. 5c). Fig. 5b and d show densitometric
quantifications of active form Rho-A and Rac-1 when normal-
ized to control values of total Rho-A or Rac-1, respectively. Our
data indicate a relationship between endocytic activity and
active form Rho-A, as well as between cell density, cellular
differentiation and endocytic slow-down, respectively, and
active form Rac-1. These findings suggest an involvement of
Rho-A and Rac-1 in regulating the endocytosis of the two CPPs
in the context of cellular differentiation.
CPP internalization in an inflammatory MDCK model. To
further elaborate our findings towards a relation between
endocytic slow-down and cellular differentiation, we studied
CPP internalization in MDCK monolayers featuring a com-
promised tight junctional organization. Therefore, prior to
incubation with CPPs, fully organized MDCK monolayers
were treated with MDCK medium containing IFN-g and TNF-
! at stepwise increased concentrations. As shown in Fig. 6,
CPP internalization was significantly enhanced upon such
inflammatory pre-treatment. A combination of IFN-g and
TNF-! provided synergistic effects on epithelial barrier func-
tion (66,67), whereas IFN-g or TNF-! alone were less effective.
Transepithelial permeability and cytotoxicity in an in-
flammatory MDCK model. To further evaluate the effects
resulting from inflammatory cytokine pre-treatments, we
determined the transepithelial permeability of CF and [3H]-
mannitol in confluent MDCK monolayers with and without
prior cytokine pre-treatment. Cell culture inserts featured
TEER values of 120 T 12 W cm2 for untreated MDCK layers.
When MDCK monolayers were treated with a IFN-g/TNF-!
mix of 1:100 ng/ml within 24 h, TEER values decreased
significantly (36 T 9 W cm2) and stayed at low values within
the investigated time interval of 48 h. Removal of the
cytokine mix led to a complete recovery to normal TEER
values within 72 h (data not shown).
As demonstrated in Fig. 7a, pre-treatments with IFN-g/
TNF-! increased the permeability of [3H]-mannitol in a time
and concentration dependent fashion. This was confirmed by
a concomitant increase in CF flux in the same time and
concentration dependent manner (Fig. 7b). Cytokine
concentrations and application periods correlated directly
with disintegrations per minute (DPM) and permeability
coefficients, respectively.
To investigate cell viability after cytokine pre-treatment,
we performed a series of MTT toxicity assays. Even at the
Fig. 3. Endocytic internalization into MDCK cells varying in differ-
entiation states (FACS). MDCK cells ranging from 12 h to 10 days
post seeding were incubated for 3 h with 30 mM FITC-dextran, 5 mM
Tat(FITC) or 30 mM CF-hCT(9-32)-br from the apical side and with
30 mM transferrin from the basolateral side. Fluorescence intensities
were normalized to untreated control cells of the same age.
Table II. Fluorescence Intensities (%) of CF-SAP and CF-hCT(9-32)-
br in MDCK Cells Varying in Growing Period and Seeding Density
Growing period (Seeding density)
Flourescence intensity (%)
CF-SAP CF-hCT(9-32)-br
0.5 days (2 104 cells/cm2) 100 T 9.16 100 T 2.49
1 day (2 104 cells/cm2) 65.61 T 3.12 64.91 T 4.47
10 days (2 104 cells/cm2) 7.42 T 0.14 7.56 T 0.43
0.5 days (5 105 cells/cm2) 14.94 T 0.21 18.01 T 0.78
1 day (5 105 cells/cm2) 8.1 T0.08 8.72 T 0.08
Fluorescence intensities are normalized to control cells of the same
age.
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highest cytokine concentration, i.e. 1,000 ng/ml for each IFN-g
and TNF-!, cell viability was reasonably preserved at 80% as
compared to untreated control cells and EtOH treated cells.
Viabilities were even better at lower concentrations.
Cytokines induce redistribution of the tight junction
protein ZO-1. Cytokine-induced redistribution of tight junc-
tion proteins to the membrane has been observed by
Bruewer et al. (67). To visualize changes in the distribution
Fig. 4. TEER measurement. (a) Transepithelial electrical resistance (TEER) was measured in MDCK cells ranging from 12 h to 10 days post
seeding. To obtain values independent of the membrane area, TEER measurements were multiplied by the effective membrane area and
reported as W cm2. All measurements are reported as net TEER (total minus the mean TEER of two cell-free inserts). Tight junctional
plaque protein ZO-1 staining. (b) ZO-1 staining was performed in MDCK cells ranging from 12 h to 10 days post seeding. The scale bar is 20 mm.
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of the tight junction protein ZO-1 due to cytokine treatment,
we performed ZO-1 staining in cytokine pre-treated MDCK
cells (IFN-g/TNF-! 1:100 ng/ml) and compared it to ZO-1
staining in control cells. As shown in Fig. 8b, cytokine
exposure induced redistribution of the plaque protein ZO-1
as compared to control cells (Fig. 8a). Redistribution was in a
cytokine concentration-dependent way (data not shown).
Involvement of lipid rafts in enhanced internalization in
inflammatory MDCK model. As demonstrated in Fig. 2a and
b, lipid rafts play a significant role in the endocytosis of CPPs
in proliferating but not in confluent MDCK cells. Cytokine
pre-treatments of confluent MDCK restored much of the
propensity for lipid raft mediated endocytosis. This is
demonstrated by the inhibitory effect of M-b-CD on the
internalization of CF-SAP and CF-hCT(9-32)-br in cytokine
pre-treated, confluent MDCK. The reduction in CPP inter-
nalization was in a cytokine concentration-dependent fashion
(Fig. 8c and d). For the studied inflammatory model, a
redistribution of tight junction proteins which have been
described to be associated with lipid raft microdomains
(67,68) might lead to a concomitant restoration of lipid rafts
on confluent MDCK cultures, reconstituting the propensity
for lipid raft-mediated endocytosis of CPPs.
DISCUSSION
In recent years, increasing numbers of CPPs have been
discovered and evaluated for their ability to deliver therapeutics
into cells that otherwise cannot translocate cellular mem-
branes. In this work, we investigated the effect of cell density
and differentiation state on the internalization kinetics and
pathways of two CPPs in epithelial cell models and the
thereby observed differentiation restricted endocytic slow-
down. In particular, we suggest involvement of Rho GTPases
in the endocytosis of CPPs. Furthermore, based on internal-
ization studies in a cytokine induced inflammatory epithelial
model, we allude to inflammatory epithelia as potential niche
for a clinical future of CPPs as vectors for anti-inflammatory
therapeutics.
Up to date, most in vitro internalization studies with
CPPs were carried out in proliferating, Bleaky^ cell models
devoid of tissular characteristics or junctional complexes
(19–23). For our studies we chose the kidney epithelial
MDCK cell line. When grown to confluence, MDCK cells
feature typical characteristics of polarized epithelia and
mimic the epithelial organization of drug absorption sites,
such as the respiratory and intestinal mucosae. Quite
Fig. 5. Active form Rho-GTPases. Contents of GTP-bound, active form Rho-A (a) and Rac-1 (c), respectively, were measured in 1 day old
cells with low or high seeding density as well as in 10 day old, well-differentiated MDCK cells with low seeding density but high final cell
culture density and compared to total Rho-GTPase contents. (b) and (d) show quantification of active form Rho-A and Rac-1 when
normalized to control values of total Rho-A or Rac-1, respectively.
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different to the efficient internalization of Tat peptides into
proliferating cell cultures, Violini et al. (23) observed a lack
of intracellular accumulation of fluorescein conjugated Tat-
peptide in confluent MDCK and CaCo-2 cells. By contrast,
Bleaky^ cell models, such as HeLa and KB 3-1 cells, showed
cytoplasmic and nuclear accumulation. In one of our previous
studies to this subject, using linear human calcitonin derived
CPPs, Tat(47-57) and penetratin(43-58), internalization into
proliferating HeLa cells was superior to that in a fully
polarized and differentiated MDCK model (7). Similarly,
Zhang et al. (24) suggested a cell type-specific barrier to
control the internalization of RI-Tat-9 into HeLa, MT2,
MDCK and Caco-2 cells.
Previously we observed marked internalization efficiency
in HeLa cells for the linear proline-rich sweet arrow peptide
CF-SAP (Table I) (15–17) and the branched derivative of the
linear human calcitonin derived CPP CF-hCT(9-32) (7),
denoted as CF-hCT(9-32)-br (Table I) (14). Both CPPs were
readily taken up by HeLa cells through lipid raft-mediated
endocytosis followed by endosomal escape (18). In the current
study in proliferating MDCK cells, the data suggested
concomitant lipid raft-mediated endocytosis and endocytosis
via clathrin coated pits, indicating a cell line specific contrast to
the pathway found in HeLa cells. After reaching confluence,
however, internalization of the investigated CPPs in MDCK
monolayers dropped drastically. Hallbrink et al. (34) found
similar differences in intracellular MAP and penetratin uptake
in CHO cells to correlate to the peptide-to-cell ratio, but due
to differences in cell seeding densities, rather than culture time.
Therefore, we investigated in more detail the impact of
cellular differentiation on efficiency and mechanism of CPP
internalization through lipid raft-mediated endocytosis. By
comparing proliferating versus confluent MDCK cell cultures,
we found the slow-down in endocytic activity to be related
with the increasing cell culture density on the one hand, and
the formation of tight junctions on the other. The observed
slow-down was not specific for the two investigated CPPs but
compound unspecific as it was shared with several common
markers of endocytosis.
To find out more about the underlying process controlling
the endocytic slow-down of the CPPs, we analysed the
occurence of active Rho-GTPases, Rho-A and Rac-1, in
MDCK layers of different states of differentiation. Rho-
GTPases are known to regulate a variety of cellular events such
as actin polymerization, cell morphology and polarity, cell
growth control, transcription and membrane trafficking events
such as endocytosis (36–42). Apparently, Rho-GTPases medi-
ate the signalling interface between endocytic traffic and actin
cytoskeleton and, through cytoskeletal modification, affect
epithelial barrier function (43–45). For several cellular func-
tions inverse activities of Rho-A versus Rac-1 and Cdc42
GTPases have been observed (36,62,69,70), such as in actin
reorganization and capacity to affect endocytosis. In polarized
MDCK cells, Rho-A activation has been found to stimulate
apical and basolateral endocytosis whereas Rac-1 activation
led to decreases in apical and basolateral endocytosis (69,70).
During the formation of epithelia, Cdc42 and Rac-1 play a
prominent role in the generation of intimate cell-to-cell
contacts (36,71,72). Up until now, the role of Rho GTPases
in the endocytosis of CPPs is unknown.
Our findings suggest an involvement of Rho-family
GTPases in the differentiation restricted regulation of CPP
endocytosis. The extent of CPP uptake was directly related with
active form Rho-A, whereas active form Rac-1 related with cell
density, cellular differentiation and endocytic slow-down. This
reflects the mentioned inverse roles of Rho-A and Rac-1. To
our knowledge, this is the first study to cast light on the cell line
and differentiation restricted endocytosis of CPPs into epithe-
lial cell models and its underlying cellular mechanism.
We further studied an interesting correspondence be-
tween endocytic slow-down and cellular differentiation in an
inflammatory MDCK model that was used to mimic inflam-
Fig. 6. Net increase of CPP internalization into an inflammatory
MDCK model by FACS. Fully organized MDCK monolayers were
treated with MDCK medium containing IFN-g and TNF-! in
concentrations ranging from 0–1000 ng/ml, prior to incubation with
50 mM CF-SAP, 30 mM CF-hCT(9-32)-br or 5 mM Tat(FITC) for 3 h.
Fluorescence intensities are normalized to control cells. Significant
(p = 0.05) and highly significant (p = 0.01) results are indicated as or
(t test, n = 3).
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matory pathologies of epithelia. Typically, inflammatory
epithelial diseases, such as inflammatory bowel disease, or
airway diseases originating from cystic fibrosis or asthma
bronchiale, are associated with elevated cytokine production
and significant barrier dysfunction (46–52). We found the
internalization efficiency of CPPs in the inflammatory
MDCK model to be largely enhanced as compared to
untreated control. Depending on cytokine concentration,
endocytosis of CPP increased by up to almost 90%,
concomitant with an increase in permeability of [3H]-
mannitol as a marker for paracellular permeability. By
analysis of cell viability we could show that enhanced
endocytosis and paracellular permeability, secondary to
cytokine treatments, were not related to cell death, at least
not under the conditions tested. Nevertheless, small transient
conductive leaks are likely to occur (73). Fish et al. (66)
suggested that TNF-! may have synergistic effects on IFN-g
mediated alterations of epithelial cell function. In fact, the
combined cytokine treatment of IFN-g and TNF-! allowed
lower concentrations of the cytokines in favour of lower toxicity
profiles as compared to non-combined cytokine treatments.
Bruewer et al. (67) found the exposure of epithelia to
cytokines to induce a redistribution of tight junctional
proteins that was not associated with a significant change in
the total levels of these proteins, suggesting protein redistri-
bution rather than membrane degradation. Changes in tight
junctional functionality have been implicated in the patho-
genesis of several inflammatory epithelial diseases. For
instance, redistribution of tight junction proteins was ob-
served in patients suffering from active inflammatory bowel
disease (IBD), where inflammatory cytokines such as IFN-g
and TNF-! were elevated (74,75). Increased levels of
inflammatory cytokines were also found on the bronchial
epithelia of cystic fibrosis patients (76) and on the gastric
epithelium of patients infected with Helicobacter pylori (77).
On the cellular level, changes in the integrity of tight
junctions in combination with a redistribution of tight
junctional proteins were observed in primary human airway
epithelial cells from cystic fibrosis patients (51). In line with
these findings, we demonstrated that the cytokine pre-
treatment of MDCK monolayers led to a redistribution of
the tight junctional plaque protein ZO-1 in a concentration
dependent way. Previously, Nusrat et al. (68) denoted tight
junctions as lipid raft membrane microdomains, enriched in
cholesterol, and featuring an affiliation of the tight junction
proteins with Triton X-100-insoluble membrane rafts. The
degree of affiliation was only marginally affected by the
cytokine pre-treatment. Furthermore, cytokines did not alter
the overall biophysical properties of membrane rafts (67).
The present study suggests lipid rafts to be crucial for the
endocytosis of CPPs in proliferating MDCK cells. Contrast-
ingly, they were not measurably involved in the internaliza-
tion process into confluent layers. Interestingly, when
confluent MDCK cells were treated with cytokines, lipid
rafts regained their role in mediating the endocytosis of
CPPs. In fact, the cellular internalization of both CPPs was
markedly reduced—in a cytokine concentration dependent
manner—upon extraction of cholesterol with M-b-CD. We
thus conclude that—under inflammatory conditions—the
redistribution of tight junction proteins associated with lipid
Fig. 7. Transepithelial permeability and cytotoxicity in an inflamma-
tory MDCK model. Transepithelial permeability of [3H]-mannitol (a)
and CF (b) was measured in confluent MDCK monolayers with or
without prior pre-treatment with cytokines (IFN-g and TNF-! in
concentrations ranging from 0–1,000 ng/ml). CF concentrations
transported into the basolateral compartment were expressed as
mM cmj2 hj1. (c) shows an MTT assay in confluent MDCK
monolayers pre-treated with IFN-g and TNF-! in concentrations
ranging from 0–1,000 ng/ml. Untreated control cells and cells treated
with EtOH as a positive control were included.
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raft microdomains (67,68) re-opens the lipid raft mediated
pathway for CPPs in confluent MDCK cells. This observation
could make our findings particularly interesting for CPP
mediated, targeted delivery of anti-inflammatory drugs and
may explain previous empirical observations on the CPP
mediated delivery of cyclosporine A to inflammatory epithelia
(78) or of caveolin-1 scaffolding domain against vasodilatation
and nitric oxide production (79). Nevertheless, the therapeutic
potential of this approach has yet to be demonstrated.
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Fig. 8. Distribution of tight junctional plaque protein ZO-1 with or without prior cytokine treatment (CLSM). (a) and (b) ZO-1 staining in
cytokine pre-treated confluent MDCK cells (IFN-g/TNF-! 100/1 ng/ml) was compared to ZO-1 staining in control cells. Maximum intensity
projection is shown. The scale bar is 20 mm. (c) and (d) MDCK cells were pre-treated with IFN-g and TNF-! in concentrations ranging from
0–1,000 ng/ml prior to incubation for 3 h with 50 mM CF-SAP (c) or 30 mM CF-hCT(9-32)-br (d). Additionally, cholesterol depletion was
performed by pre-treating cells with 10 mM M-b-CD before incubation with CF-SAP or CF-hCT(9-32)-br. Fluorescence intensities are
normalized to control cells. Significant and highly significant results for the reduction of internalization through M-b-CD are indicated as or
(t test, n = 5).
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